Publication:
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.

Simple item page
dc.contributor.authorBusca, Alessandro
dc.contributor.authorSalmanton-García, Jon
dc.contributor.authorCorradini, Paolo
dc.contributor.authorMarchesi, Francesco
dc.contributor.authorCabirta, Alba
dc.contributor.authorDi Blasi, Roberta
dc.contributor.authorDulery, Remy
dc.contributor.authorLamure, Sylvain
dc.contributor.authorFarina, Francesca
dc.contributor.authorWeinbergerová, Barbora
dc.contributor.authorBatinić, Josip
dc.contributor.authorNordlander, Anna
dc.contributor.authorLópez-García, Alberto
dc.contributor.authorDrgoňa, Ľuboš
dc.contributor.authorEspigado-Tocino, Ildefonso
dc.contributor.authorFalces-Romero, Iker
dc.contributor.authorGarcía-Sanz, Ramón
dc.contributor.authorGarcía-Vidal, Carolina
dc.contributor.authorGuidetti, Anna
dc.contributor.authorKhanna, Nina
dc.contributor.authorKulasekararaj, Austin
dc.contributor.authorMaertens, Johan
dc.contributor.authorHoenigl, Martin
dc.contributor.authorKlimko, Nikolai
dc.contributor.authorKoehler, Philipp
dc.contributor.authorPagliuca, Antonio
dc.contributor.authorPassamonti, Francesco
dc.contributor.authorCornely, Oliver A
dc.contributor.authorPagano, Livio
dc.date.accessioned2023-05-03T13:32:50Z
dc.date.available2023-05-03T13:32:50Z
dc.date.issued2022
dc.description.abstractThe EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
dc.identifier.doi10.1182/bloodadvances.2021005616
dc.identifier.essn2473-9537
dc.identifier.pmcPMC8575532
dc.identifier.pmid34749396
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575532/pdf
dc.identifier.unpaywallURLhttps://ashpublications.org/bloodadvances/article-pdf/6/7/2427/1887717/advancesadv2021005616.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20249
dc.issue.number7
dc.journal.titleBlood advances
dc.journal.titleabbreviationBlood Adv
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number2427-2433
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshCOVID-19
dc.subject.meshHumans
dc.subject.meshImmunotherapy, Adoptive
dc.subject.meshReceptors, Chimeric Antigen
dc.subject.meshT-Lymphocytes
dc.titleCOVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number6
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8575532.pdf
Size:
832.28 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía